α-Lipoic acid (LA) is a thiol with antioxidant properties that protects against oxidative stress-induced apoptosis. LA is absorbed from the diet, taken up by cells and tissues, and subsequently reduced to dihydrolipoic acid (DHLA). In view of the recent application of DHLA as a hydrophilic nanomaterial preparation, determination of its biosafety profile is essential. In the current study, we examined the cytotoxic effects of DHLA on mouse embryos at the blastocyst stage, subsequent embryonic attachment and outgrowth in vitro, in vivo implantation by embryo transfer, and early embryonic development in an animal model. Blastocysts treated with 50 μM DHLA exhibited significantly increased apoptosis and a corresponding decrease in total cell number. Notably, the implantation success rates of blastocysts pretreated with DHLA were lower than that of their control counterparts. Moreover, in vitro treatment with 50 μM DHLA was associated with increased resorption of post-implantation embryos and decreased fetal weight. Data obtained using an in vivo mouse model further disclosed that consumption of drinking water containing 100 μM DHLA led to decreased early embryo development, specifically, inhibition of development to the blastocyst stage. However, it appears that concentrations of DHLA lower than 50 μM do not exert a hazardous effect on embryonic development. Our results collectively indicate that in vitro and in vivo exposure to concentrations of DHLA higher than 50 μM DHLA induces apoptosis and retards early pre- and post-implantation development, and support the potential of DHLA to induce embryonic cytotoxicity.
References
[1]
Reed, L.J. A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. J. Biol. Chem 2001, 276, 38329–38336.
Bilska, A.; Wlodek, L. Lipoic acid—the drug of the future? Pharmacol. Rep 2005, 57, 570–577.
[4]
Packer, L.; Tritschler, H.J.; Wessel, K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med 1997, 22, 359–378.
[5]
Morkunaite-Haimi, S.; Kruglov, A.G.; Teplova, V.V.; Stolze, K.; Gille, L.; Nohl, H.; Saris, N.E. Reactive oxygen species are involved in the stimulation of the mitochondrial permeability transition by dihydrolipoate. Biochem. Pharmacol 2003, 65, 43–49.
[6]
Scott, B.C.; Aruoma, O.I.; Evans, P.J.; O’Neill, C.; Van der Vliet, A.; Cross, C.E.; Tritschler, H.; Halliwell, B. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic. Res 1994, 20, 119–133.
[7]
Simbula, G.; Columbano, A.; Ledda-Columbano, G.M.; Sanna, L.; Deidda, M.; Diana, A.; Pibiri, M. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 2007, 12, 113–123.
[8]
Moungjaroen, J.; Nimmannit, U.; Callery, P.S.; Wang, L.; Azad, N.; Lipipun, V.; Chanvorachote, P.; Rojanasakul, Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J. Pharmacol. Exp. Ther 2006, 319, 1062–1069.
[9]
Zheng, Y.; Yamaguchi, H.; Tian, C.; Lee, M.W.; Tang, H.; Wang, H.G.; Chen, Q. Arsenic trioxide (As(2)O(3)) induces apoptosis through activation of Bax in hematopoietic cells. Oncogene 2005, 24, 3339–3347.
[10]
Singh, L.P.; Cheng, D.W.; Kowluru, R.; Levi, E.; Jiang, Y. Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: Effect of the anti-oxidant alpha-lipoic acid. Cell. Biochem. Funct 2007, 25, 537–550.
[11]
Abdul, H.M.; Butterfield, D.A. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-l-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease. Free Radic. Biol. Med 2007, 42, 371–384.
[12]
Choi, S.Y.; Yu, J.H.; Kim, H. Mechanism of alpha-lipoic acid-induced apoptosis of lung cancer cells. Ann. NY Acad. Sci 2009, 1171, 149–155.
[13]
Chan, W.H.; Houng, W.L.; Lin, C.A.; Lee, C.H.; Li, P.W.; Hsieh, J.T.; Shen, J.L.; Yeh, H.I.; Chang, W.H. Impact of dihydrolipoic acid on mouse embryonic stem cells and related regulatory mechanisms. Environ. Toxicol 2011, doi:10.1002/tox.20700.
[14]
Liu, W.; Howarth, M.; Greytak, A.B.; Zheng, Y.; Nocera, D.G.; Ting, A.Y.; Bawendi, M.G. Compact biocompatible quantum dots functionalized for cellular imaging. J. Am. Chem. Soc 2008, 130, 1274–1284.
[15]
Lin, C.A.; Yang, T.Y.; Lee, C.H.; Huang, S.H.; Sperling, R.A.; Zanella, M.; Li, J.K.; Shen, J.L.; Wang, H.H.; Yeh, H.I.; et al. Synthesis, characterization, and bioconjugation of fluorescent gold nanoclusters toward biological labeling applications. ACS Nano 2009, 3, 395–401.
[16]
Lin, C.-A.J.; Lee, C.-H.; Hsieh, J.-T.; Wang, H.-H.; Li, J.K.; Shen, J.-L.; Chan, W.-H.; Yeh, H.-I.; Chang, W.H. Synthesis of fluorescent metallic nanoclusters toward biomedical application: Recent progress and present challenges. J. Med. Biol. Eng 2009, 29, 276–283.
[17]
Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267, 1456–1462.
[18]
Brill, A.; Torchinsky, A.; Carp, H.; Toder, V. The role of apoptosis in normal and abnormal embryonic development. J. Assist. Reprod. Genet 1999, 16, 512–519.
[19]
Lotz, K.; Proff, P.; Bienengraeber, V.; Fanghaenel, J.; Gedrange, T.; Weingaertner, J. Apoptosis as a creative agent of embryonic development of bucca, mentum and nasolacrimal duct. An in vivo study in rats. J. Craniomaxillofac. Surg 2006, 34, 8–13.
[20]
Weingaertner, J.; Proff, P.; Bienengraeber, V.; Gedrange, T.; Fanghaenel, J.; Lotz, K. In vivo study of apoptosis as a creative agent of embryonic development of the primary nasal duct in rats. J. Craniomaxillofac. Surg 2006, 34, 3–7.
[21]
Huang, F.J.; Shen, C.C.; Chang, S.Y.; Wu, T.C.; Hsuuw, Y.D. Retinoic acid decreases the viability of mouse blastocysts in vitro. Hum. Reprod 2003, 18, 130–136.
[22]
Hsuuw, Y.D.; Chang, C.K.; Chan, W.H.; Yu, J.S. Curcumin prevents methylglyoxal-induced oxidative stress and apoptosis in mouse embryonic stem cells and blastocysts. J. Cell. Physiol 2005, 205, 379–386.
[23]
Chan, W.H. Ginkgolide B induces apoptosis and developmental injury in mouse embryonic stem cells and blastocysts. Hum. Reprod 2006, 21, 2985–2995.
[24]
Shang, E.H.; Wu, R.S. Aquatic hypoxia is a teratogen and affects fish embryonic development. Environ. Sci. Technol 2004, 38, 4763–4767.
[25]
Detmar, J.; Rabaglino, T.; Taniuchi, Y.; Oh, J.; Acton, B.M.; Benito, A.; Nunez, G.; Jurisicova, A. Embryonic loss due to exposure to polycyclic aromatic hydrocarbons is mediated by Bax. Apoptosis 2006, 11, 1413–1425.
[26]
Selvakumar, E.; Hsieh, T.C. Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by lipoic acid: role in cancer prevention and therapy. J. Hematol. Oncol 2008, 1, 4.
[27]
Huang, F.J.; Hsuuw, Y.D.; Lan, K.C.; Kang, H.Y.; Chang, S.Y.; Hsu, Y.C.; Huang, K.E. Adverse effects of retinoic acid on embryo development and the selective expression of retinoic acid receptors in mouse blastocysts. Hum. Reprod 2006, 21, 202–209.
[28]
Chan, W.H. Impact of genistein on maturation of mouse oocytes, fertilization, and fetal development. Reprod. Toxicol 2009, 28, 52–58.
[29]
Chan, W.H.; Shiao, N.H. Cytotoxic effect of CdSe quantum dots on mouse embryonic development. Acta Pharmacol. Sin 2008, 29, 259–266.
[30]
Chan, W.H.; Shiao, N.H. Effect of citrinin on mouse embryonic development in vitro and in vivo. Reprod. Toxicol 2007, 24, 120–125.
[31]
Hardy, K. Cell death in the mammalian blastocyst. Mol. Hum. Reprod 1997, 3, 919–925.
[32]
Hardy, K.; Stark, J.; Winston, R.M. Maintenance of the inner cell mass in human blastocysts from fragmented embryos. Biol. Reprod 2003, 68, 1165–1169.
[33]
Byrne, A.T.; Southgate, J.; Brison, D.R.; Leese, H.J. Analysis of apoptosis in the preimplantation bovine embryo using TUNEL. J. Reprod. Fertil 1999, 117, 97–105.
[34]
Chan, W.H. Effects of citrinin on maturation of mouse oocytes, fertilization, and fetal development in vitro and in vivo. Toxicol. Lett 2008, 180, 28–32.
[35]
Chan, W.H. Ginkgolides induce apoptosis and decrease cell numbers in mouse blastocysts. Biochem. Biophys. Res. Commun 2005, 338, 1263–1267.
[36]
Cross, J.C.; Werb, Z.; Fisher, S.J. Implantation and the placenta: Key pieces of the development puzzle. Science 1994, 266, 1508–1518.
[37]
Pampfer, S.; de Hertogh, R.; Vanderheyden, I.; Michiels, B.; Vercheval, M. Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 1990, 39, 471–476.
Tam, P.P. Postimplantation development of mitomycin C-treated mouse blastocysts. Teratology 1988, 37, 205–212.
[40]
Hardy, K.; Handyside, A.H.; Winston, R.M. The human blastocyst: Cell number, death and allocation during late preimplantation development in vitro. Development 1989, 107, 597–604.
[41]
Gardner, R.L.; Davies, T.J. Lack of coupling between onset of giant transformation and genome endoreduplication in the mural trophectoderm of the mouse blastocyst. J. Exp. Zool 1993, 265, 54–60.
[42]
Huang, F.J.; Wu, T.C.; Tsai, M.Y. Effect of retinoic acid on implantation and post-implantation development of mouse embryos in vitro. Hum. Reprod 2001, 16, 2171–2176.
[43]
Witschi, E. Characterization of Developmental Stages. Part II. Rat. In Biology Data Book, 2nd ed ed.; Federation of American Societies of Experimental Biologies: Washington DC, USA, 1972; pp. 178–180.
[44]
Armant, D.R.; Kaplan, H.A.; Lennarz, W.J. Fibronectin and laminin promote in vitro attachment and outgrowth of mouse blastocysts. Dev. Biol 1986, 116, 519–523.
[45]
Pampfer, S.; Wuu, Y.D.; Vanderheyden, I.; de Hertogh, R. In vitro study of the carry-over effect associated with early diabetic embryopathy in the rat. Diabetologia 1994, 37, 855–862.
